This article first appeared on GuruFocus.
iShares S&P Mid-Cap 400 Growth ETF (IJK) extended its run of one-sided ETF activity on Tuesday, Nov. 10, reporting $119.8 million in gross trades that were entirely buys. The fund increased 245 positions and decreased none, leaving its net bought figure at the same $119.8 million against $10.58 billion in assets under management.
What did IJK buy on Tuesday?
Its largest buys by dollar value were FTI ($1.8 million), UTHR ($1.8 million) and ATI ($1.7 million).
The largest buys were all existing holdings, topped by TechnipFMC PLC and United Therapeutics, which each drew $1.8 million and sat at 1.49% of assets after additions of 27,277 and 2,977 shares respectively. ATI followed at $1.7 million on a 9,449-share increase, while Tenet Healthcare Corp and Royal Gold each took in $1.6 million, with weights of 1.38% and 1.37%. No new positions were opened and no holdings were sold out, and the fund reported no sells.
How does IJK invest?
iShares S&P Mid-Cap 400 Growth ETF (IJK) is an equity fund in the Equity US Sm&Mid Cap category, holding 246 stocks with 12.9% of assets in its 10 largest holdings. Industrials make up 26.2% of the stocks that could be classified, followed by Technology at 19.4% and Healthcare at 18.2%, while the cap mix is 62.4% large-cap and 37.6% mid-cap. It charges an expense ratio of 0.16%, and its top holdings are TechnipFMC PLC at 1.49%, United Therapeutics at 1.49%, ATI at 1.47%, Tenet Healthcare Corp at 1.38% and Royal Gold at 1.37%. The fund has a GF Score of 84, a P/E of 26.32, a P/B of 4.35, a dividend yield of 0.7% and a year-to-date return of 14.37%.
iShares S&P Mid-Cap 400 Growth ETF (IJK) at a glance
See the full iShares S&P Mid-Cap 400 Growth ETF profile, or compare it with similar funds in the ETF Screener. For the stock behind its biggest buy, see FTI’s GF Value page and guru trades.
